Tetrahydrocinnolines as 11 beta HSD1 inhibitors for diabetes

Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein A and R1 to R3 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.